Skip to content
    RCUS stock page

    Arcus Biosciences, Inc.

    RCUS · earnings call history

    2 calls analysed
    1. Jun 2026Q2 FY26Aug 05, 2026

      Arcus Biosciences, Inc. Q2 FY26 — Casdatifan Advances Across RCC Treatment Lines with Key Data Readouts Expected

      Read the brief
    2. Dec 2025Q4 FY25Feb 25, 2026

      Arcus Biosciences Q4 FY25 — Casdatifan's Best-in-Class Profile and Frontline RCC Strategy

      Read the brief

    Browse all US companies on the earnings-call register.